Roanne Segal

10.3k total citations · 3 hit papers
70 papers, 7.6k citations indexed

About

Roanne Segal is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roanne Segal has authored 70 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 24 papers in Pediatrics, Perinatology and Child Health and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roanne Segal's work include Cancer survivorship and care (36 papers), Childhood Cancer Survivors' Quality of Life (23 papers) and Lymphatic System and Diseases (21 papers). Roanne Segal is often cited by papers focused on Cancer survivorship and care (36 papers), Childhood Cancer Survivors' Quality of Life (23 papers) and Lymphatic System and Diseases (21 papers). Roanne Segal collaborates with scholars based in Canada, United States and India. Roanne Segal's co-authors include Kerry S. Courneya, Robert D. Reid, John R. Mackey, Christine M. Friedenreich, Donald C. McKenzie, Karen A. Gelmon, Robert D. Reid, George A. Wells, Wendy Demark‐Wahnefried and Charles E. Matthews and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Roanne Segal

70 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors

2010 2.1k citations Kerry S. Courneya, Roanne Segal et al. Medicine & Science in Sports & Exercise profile →
Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial

2007 866 citations Kerry S. Courneya, Roanne Segal et al. profile →
Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

2003 614 citations Roanne Segal, Robert D. Reid et al. profile →

Peers

Countries citing papers authored by Roanne Segal

Since Specialization

Citations

This map shows the geographic impact of Roanne Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roanne Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roanne Segal more than expected).

Fields of papers citing papers by Roanne Segal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roanne Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roanne Segal. The network helps show where Roanne Segal may publish in the future.

Co-authorship network of co-authors of Roanne Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Roanne Segal. A scholar is included among the top collaborators of Roanne Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roanne Segal. Roanne Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial 2023 ·Journal of Medical Internet Research ·(unknown), Jim A. Julian, Clare Liddy, Amir Afkham, Sharon F. McGee, Scott C. Morgan, Roanne Segal, Jonathan Sussman, Gregory R. Pond, Mary Ann O’Brien, Jacqueline L. Bender, Eva Grunfeld	4
2	Randomized trial of surveillance with abbreviated MRI in women with a personal history of breast cancer– impact on patient anxiety and cancer detection 2022 ·BMC Cancer ·(unknown), (unknown), (unknown), Diana Koszycki, (unknown), Roanne Segal, Angel Arnaout, Tim Ramsay, (unknown), Jean M. Seely	2
3	The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer 2020 ·npj Breast Cancer ·Pamela J. Goodwin, Roanne Segal, Michael Vallis, Jennifer A. Ligibel, Gregory R. Pond, André Robidoux, B. Findlay, Julie R. Gralow, Som D. Mukherjee, Mark N. Levine, Kathleen I. Pritchard	33
4	Exercise for People with Cancer: A Systematic Review 2017 ·Current Oncology ·Roanne Segal, Caroline Zwaal, (unknown), Jennifer R. Tomasone, Andrew Loblaw, Teresa M. Petrella, (unknown)	111
5	Can the Referring Surgeon Enhance Accrual of Breast Cancer Patients to Medical and Radiation Oncology Trials? The Enhance Study 2016 ·Current Oncology ·Angel Arnaout, Iryna Kuchuk, Nathaniel Bouganim, Gregory R. Pond, S. Verma, Roanne Segal, Susan Dent, S. Gertler, (unknown), Femina Kanji, Mark Clemons	10
6	A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy 2015 ·BMC Cancer ·Shabbir M.H. Alibhai, Daniel Santa Mina, Paul Ritvo, Catherine M. Sabiston, Murray Krahn, George Tomlinson, Andrew Matthew, Roanne Segal, Padraig Warde, (unknown), (unknown), Nicole Culos-Reed	16
7	A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events 2014 ·Breast Cancer Research and Treatment ·Christina Addison, Nathaniel Bouganim, John Hilton, Lisa Vandermeer, Susan Dent, Eitan Amir, Sean Hopkins, Iryna Kuchuk, Roanne Segal, Xinni Song, S. Gertler, Sasha Mazzarello, George Dranitsaris, Daylily S Ooi, Gregory R. Pond, Mark Clemons	21
8	Effects of Exercise during Adjuvant Chemotherapy on Breast Cancer Outcomes 2014 ·Medicine & Science in Sports & Exercise ·Kerry S. Courneya, Roanne Segal, Donald C. McKenzie, Huiru Dong, Karen A. Gelmon, Christine M. Friedenreich, Yutaka Yasui, Robert D. Reid, Jennifer Crawford, John R. Mackey	197
9	Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial 2014 ·Breast Cancer Research and Treatment ·Kerry S. Courneya, Roanne Segal, John R. Mackey, Karen A. Gelmon, Christine M. Friedenreich, Yutaka Yasui, Robert D. Reid, D. K. Jespersen, Diane J. Cook, (unknown), Linda Trinh, Lianne B. Dolan, Evyanne Wooding, Cynthia C. Forbes, Donald C. McKenzie	67
10	Preference weights for chemotherapy side effects from the perspective of women with breast cancer 2013 ·Breast Cancer Research and Treatment ·Iryna Kuchuk, Nathaniel Bouganim, (unknown), (unknown), Lisa Vandermeer, S. Gertler, Susan Dent, (unknown), Roanne Segal, Sasha Mazzarello, (unknown), George Dranitsaris, Mark Clemons	71
11	Clinical benefits of alpharadin in castrate-chemotherapy-resistant prostate cancer: case report and literature review 2012 ·BMJ Case Reports ·Jennifer Croke, Eugene Leung, Roanne Segal, Shawn Malone	10
12	Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer 2011 ·Supportive Care in Cancer ·Angela S. Alberga, Roanne Segal, Robert D. Reid, Christopher G. Scott, Ronald J. Sigal, Farah Khandwala, James Jaffey, George A. Wells, Glen P. Kenny	62
13	Predictors of Supervised Exercise Adherence during Breast Cancer Chemotherapy 2008 ·Medicine & Science in Sports & Exercise ·Kerry S. Courneya, Roanne Segal, Karen A. Gelmon, Robert D. Reid, John R. Mackey, Christine M. Friedenreich, Caroline Proulx, Kirstin N. Lane, Aliya B. Ladha, Jeffrey K. Vallance, Donald C. McKenzie	125
14	Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy 2008 ·Cancer ·Kerry S. Courneya, Donald C. McKenzie, John R. Mackey, Karen A. Gelmon, Robert D. Reid, Christine M. Friedenreich, Aliya B. Ladha, Caroline Proulx, Jeffrey K. Vallance, Kirstin N. Lane, Yutaka Yasui, Roanne Segal	88
15	Surveillance programs for stage I nonseminomatous germ cell tumors of the testis 2006 ·Urologic Oncology Seminars and Original Investigations ·Roanne Segal	14
16	Long‐term side‐effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study 2005 ·British Journal of Urology ·Shawn Malone, Gad Perry, Roanne Segal, Simone Dahrouge, Juanita Crook	39
17	A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach 2005 ·Urologic Oncology Seminars and Original Investigations ·E Choan, Roanne Segal, Derek J. Jonker, Shawn Malone, Neil Reaume, Libni Eapen, V Gallant	94
18	Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract 2003 ·European Journal of Cancer ·Eric Winquist, D. Scott Ernst, (unknown), Malcolm J. Moore, Roanne Segal, G. Lockwood, (unknown)	17
19	Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline. 2001 ·PubMed ·Roanne Segal, Himanshu Lukka, (unknown), E. Anne Eady, (unknown), Mary Ann Johnston	15
20	Clinical Review of Adult Granulosa Cell Tumors of the Ovary 1995 ·Gynecologic Oncology ·Roanne Segal, A.D. DePetrillo, G. Thomas	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact